Inventor

Paul W. Erhardt

Inventor

Long Valley, NJ, US

Overview

36→

Patents

1983–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 36 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds40%

A61KPreparations for medical, dental or toiletry purposes18%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%

C07CAcyclic or carbocyclic compounds13%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%

C40BCombinatorial chemistry3%

G06FElectric digital data processing3%

H04WWireless communication networks3%

C07BGeneral methods of organic chemistry1%

C07KPeptides1%

PatentTitleYear

10,941,125Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same2021 10,776,461Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same2020 10,351,541Proxisome proliferator activated receptor (PPAR) compounds and methods of using the same2019 10,181,018Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same2019 9,821,008'Inhibitors of ERCC1-XPF and methods of using the same'2017 9,695,137'Analogs of peroxisome proliferator activated receptor (PPAR) agonists, and methods of using the same'2017 9,061,994'Materials and methods useful to induce vacuolization, cell death, or a combination thereof'2015 9,028,796'Materials and methods useful to induce cell death via methuosis'2015 9,023,871'Materials and Methods Useful to Induce Vacuolization, Cell Death, or a Combination Thereof'2015 8,563,599'Methods for synthesizing glycinols, glyceollins I and II, compositions of selected intermediates, and therapeutic uses thereof'2013 8,507,549'Methods for synthesizing glycinols, glyceollins I and II and isoflavenes and chromanes using a Wittig reaction, and compositions made therewith'2013 7,164,027'Aralkyl ester soft drugs'2007 7,049,326'Method and compositions for temporarily incapacitating subjects'2006 6,846,937'Method for the selective removal of acyl-functionality attached to the 2\'-hydroxy-group of paclitaxel-related derivatives'2005 6,756,047'Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs'2004 6,750,238'Aralkyl ester soft drugs'2004 6,255,540'Methods for producing two-substituted glycerols having various levels of protection'2001 5,977,409'Method of using .alpha.-substituted benzylamine chiral auxiliary synthetic reagents'1999 5,504,070'Inhibitors of the conversion of big endothelin to endothelin'1996 5,416,097'Potassium channel activators/openers'1995 5,189,036'Imidazolylbenzoyl substituted heterocycles'1993 4,906,661'Esters of aryloxypropanolamine derivatives'1990 4,804,677'Esters of aryloxypropanolamine derivatives'1989 4,743,612'Prodrug derivatives of the cardiotonic agent 4-ethyl-1,3-dihydro-5-(4-(2-methyl-1H-imidazol-1-yl)benzoyl)-2H-imidazol -2-one, composition containing them, and method of using them to treat cardiac failure'1988 4,737,511'Cardiotonic imidazolylphenylpyrrol-2-ones'1988 4,709,043'Process for the preparation of imidazolonecarbonylarylimidazoles'1987 4,692,446'Esters of aryloxypropanolamine derivatives and medicinal uses'1987 4,623,652'Esters of thiadiazole oxypropanolaine derivatives and pharmaceutical uses'1986 4,604,481'Compounds for treatment or prophylaxis of cardiac disorders'1986 4,593,119'Method for treatment or prophylaxis of cardiac disorders'1986 4,556,665'Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones'1985 4,556,668'Ethylenediamine derivatives of aryloxypropanolamine aryl esters having various medicinal properties'1985 4,508,725'Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives'1985 4,450,173'Compounds and method for treatment or prophylaxis of cardiac disorders'1984 4,405,642'Method for treatment or prophylaxis of cardiac disorders'1983 4,387,103'Method for treatment or prophylaxis of cardiac disorders'1983

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1983–1986Patents assigned to AMERICAN HOSPITAL SUPPLY CORP (8)· patent assignee history

1983–1986Based in Mundelein, IL, US· patent location history

1985–1993Patents assigned to SCHERING AG (4)· patent assignee history

1985–1996Based in Long Valley, NJ, US· patent location history

1987–1990Patents assigned to DU PONT (3)· patent assignee history

1988–1996Patents assigned to BERLEX LAB (3)· patent assignee history

1995–2013Based in Sylvania, OH, US· patent location history

1999–2021Patents assigned to UNIV TOLEDO (18)· patent assignee history

2013–2021Based in Toledo, OH, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV TOLEDO	18	1999–2021
AMERICAN HOSPITAL SUPPLY CORP	8	1983–1986
SCHERING AG	4	1985–1993
BERLEX LAB	3	1988–1996
DU PONT	3	1987–1990

Locations

Location	Patents	Span
Long Valley, New Jersey, US	11	1985–1996
Toledo, OH, US	10	2013–2021
Sylvania, OH, US	9	1995–2013
Mundelein, Illinois, US	6	1983–1986